Direct supply of naloxone by pharmacists reduces overdose deaths

In Australia, the opioid antagonist naloxone can be supplied directly from a pharmacist to patients without the need for a prescription (a Schedule 3 medicine). This scheduling change has been implemented with the intention of reducing opioid-related mortality arising...

Drug-induced hyperthermia

The Australian Prescriber has published an excellent review of acute drug-induced hyperthermia – see more here

Cannabidiol drug interaction?

There is increasing attention focused upon cannabidiol (CBD), a non‐psychoactive derivative from cannabis that is advocated for various therapeutic uses. CBD undergoes metabolism via the CYP3A4 and CYP2C19 isoenzymes, and it appears that the compound may also be a...